A detailed history of Amplius Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Amplius Wealth Advisors, LLC holds 25,912 shares of PFE stock, worth $646,245. This represents 0.09% of its overall portfolio holdings.

Number of Shares
25,912
Previous 26,016 0.4%
Holding current value
$646,245
Previous $727,000 3.03%
% of portfolio
0.09%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$27.7 - $31.39 $2,880 - $3,264
-104 Reduced 0.4%
25,912 $749,000
Q2 2024

Jul 22, 2024

SELL
$25.26 - $29.6 $49,206 - $57,660
-1,948 Reduced 6.97%
26,016 $727,000
Q1 2024

Apr 16, 2024

BUY
$25.89 - $29.73 $8,103 - $9,305
313 Added 1.13%
27,964 $776,000
Q4 2023

Jan 10, 2024

SELL
$26.13 - $33.94 $194,746 - $252,954
-7,453 Reduced 21.23%
27,651 $796,000
Q3 2023

Oct 17, 2023

SELL
$32.09 - $37.51 $34,400 - $40,210
-1,072 Reduced 2.96%
35,104 $1.16 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $16,434 - $19,014
455 Added 1.27%
36,176 $1.33 Million
Q1 2023

Apr 25, 2023

BUY
$39.39 - $51.28 $60,345 - $78,560
1,532 Added 4.48%
35,721 $1.46 Million
Q4 2022

Jan 19, 2023

BUY
$41.75 - $54.5 $71,810 - $93,740
1,720 Added 5.3%
34,189 $0
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $32,032 - $39,103
732 Added 2.31%
32,469 $1.42 Million
Q2 2022

Jul 21, 2022

SELL
$46.53 - $55.17 $12,981 - $15,392
-279 Reduced 0.87%
31,737 $1.66 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $35,364 - $43,821
-773 Reduced 2.36%
32,016 $1.66 Million
Q4 2021

Jan 28, 2022

BUY
$41.32 - $61.25 $1.35 Million - $2.01 Million
32,789 New
32,789 $1.94 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Amplius Wealth Advisors, LLC Portfolio

Follow Amplius Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amplius Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amplius Wealth Advisors, LLC with notifications on news.